Skip to main content

Research Repository

Advanced Search

Surgical Management of Focal Chondral Defects of the Talus: A Bayesian Network Meta-analysis

Surgical Management of Focal Chondral Defects of the Talus: A Bayesian Network Meta-analysis Thumbnail


Abstract

BACKGROUND: No consensus has been reached regarding the optimal surgical treatment for focal chondral defects of the talus.

PURPOSE: A Bayesian network meta-analysis was conducted to compare the clinical scores and complications of mosaicplasty, osteochondral auto- and allograft transplant, microfracture, matrix-assisted autologous chondrocyte transplant, and autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the talus at midterm follow-up.

STUDY DESIGN: Bayesian network meta-analysis; Level of evidence, 4.

METHODS: This Bayesian network meta-analysis followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions. PubMed, Embase, Google Scholar, and Scopus databases were accessed in February 2021. All clinical trials comparing 2 or more surgical interventions for the management of chondral defects of the talus were accessed. The outcomes of interest were visual analog scale (VAS) score, American Orthopaedic Foot and Ankle Society (AOFAS) score, rate of failure, and rate of revision surgery. The network meta-analysis were performed through the routine for Bayesian hierarchical random-effects model analysis. The log odds ratio (LOR) effect measure was used for dichotomous variables, and the standardized mean difference (SMD) was used for continuous variables.

RESULTS: Data from 13 articles (521 procedures) were retrieved. The median length of the follow-up was 47.8 months (range, 31.7-66.8 months). Analysis of variance revealed no difference between the treatment groups at baseline in terms of age, sex, body mass index, AOFAS score, VAS score, and mean number of defects. AMIC demonstrated the greatest AOFAS score (SMD, 11.27) and lowest VAS score (SMD, -2.26) as well as the lowest rates of failure (LOR, 0.94) and revision (LOR, 0.94). The test for overall inconsistency was not significant.

CONCLUSION: At approximately 4 years of follow-up, the AMIC procedure for management of focal chondral defects of the talus produced the best outcome.

Journal Article Type Article
Acceptance Date Sep 20, 2021
Online Publication Date Sep 20, 2021
Publication Date Sep 20, 2021
Publicly Available Date May 30, 2023
Journal The American Journal of Sports Medicine
Volume 50
Issue 10
Pages 2853-2859
DOI https://doi.org/10.1177/03635465211029642
Keywords talus; chondral defect; AMIC; OAT
Publisher URL https://doi.org/10.1177%2F03635465211029642

Files




Downloadable Citations